[HTML][HTML] Cardiac ketone body metabolism

AA Kadir, K Clarke, RD Evans - … et Biophysica Acta (BBA)-Molecular Basis …, 2020 - Elsevier
The ketone bodies, d-β-hydroxybutyrate and acetoacetate, are soluble 4-carbon compounds
derived principally from fatty acids, that can be metabolised by many oxidative tissues …

[HTML][HTML] Increased de novo ceramide synthesis and accumulation in failing myocardium

R Ji, H Akashi, K Drosatos, X Liao, H Jiang, PJ Kennel… - JCI insight, 2017 - ncbi.nlm.nih.gov
Abnormal lipid metabolism may contribute to myocardial injury and remodeling. To
determine whether accumulation of very long–chain ceramides occurs in human failing …

Modulating fatty acid oxidation in heart failure

V Lionetti, WC Stanley, FA Recchia - Cardiovascular research, 2011 - academic.oup.com
In the advanced stages of heart failure, many key enzymes involved in myocardial energy
substrate metabolism display various degrees of down-regulation. The net effect of the …

Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance

SA Cooper, A Whaley-Connell… - American Journal …, 2007 - journals.physiology.org
Hypertension commonly occurs in conjunction with insulin resistance and other components
of the cardiometabolic syndrome. Insulin resistance plays a significant role in the …

Complex energy metabolic changes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction

KA De Jong, GD Lopaschuk - Canadian Journal of Cardiology, 2017 - Elsevier
Alterations in cardiac energy metabolism contribute to the severity of heart failure. However,
the energy metabolic changes that occur in heart failure are complex, and are dependent …

Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy

H Tuunanen, E Engblom, A Naum, K Någren… - Circulation, 2008 - Am Heart Assoc
Background—The anti-ischemic agent trimetazidine improves ejection fraction in heart
failure that is hypothetically linked to inhibitory effects on cardiac free fatty acid (FFA) …

How exercise may amend metabolic disturbances in diabetic cardiomyopathy

AD Hafstad, N Boardman, E Aasum - Antioxidants & redox signaling, 2015 - liebertpub.com
Significance: Over-nutrition and sedentary lifestyle has led to a worldwide increase in
obesity, insulin resistance, and type 2 diabetes (T2D) associated with an increased risk of …

Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes …

J Oldgren, S Laurila, A Åkerblom… - Diabetes, Obesity …, 2021 - Wiley Online Library
Aim To explore the early effects of dapagliflozin on myocardial function and metabolism in
patients with type 2 diabetes without heart failure. Materials and Methods Patients with type …

Taking diabetes to heart—deregulation of myocardial lipid metabolism in diabetic cardiomyopathy

M Bayeva, KT Sawicki, H Ardehali - Journal of the American Heart …, 2013 - Am Heart Assoc
Heart disease is the leading cause of death in patients with diabetes. 1 Although advances
in medical management and lifestyle interventions have reduced cardiovascular mortality in …

p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure

I Shimizu, Y Yoshida, T Katsuno, K Tateno, S Okada… - Cell metabolism, 2012 - cell.com
Several clinical studies have shown that insulin resistance is prevalent among patients with
heart failure, but the underlying mechanisms have not been fully elucidated. Here, we report …